3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
13
Sarcoma
10
Other hematologic neoplasm
2
Lymphoid
2
Genitourinary
2
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
NET
1
Myeloid
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
164
Lung Neoplasms
61
Small Cell Lung Carcinoma
24
Neoplasms
10
NSCLC
9
Mesothelioma, Malignant
9
Breast Neoplasms
8
Pancreatic Neoplasms
7
Ovarian Neoplasms
7
Melanoma
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
6
Esophageal Neoplasms
5
Stomach Neoplasms
4
Neoplasm Metastasis
4
Mesothelioma
4
Kidney Neoplasms
4
Brain Neoplasms
4
Sarcoma
3
Pleural Effusion, Malignant
3
Liver Neoplasms
3
Fallopian Tube Neoplasms
3
Cholangiocarcinoma
3
Carcinoma
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Thymoma
2
Small Cell Lung Cancer Limited Stage
2
Skin Neoplasms
2
Interventions
Paclitaxel
3
Carboplatin
3
selpercatinib
2
Radiotherapy
2
Cisplatin
2
regorafenib
1
pentetreotide
1
pembrolizumab
1
glutathione pegylated liposomal doxorubicin
1
etoposide phosphate
1
carboxyamido-triazole
1
budigalimab
1
binimetinib
1
aflibercept
1
Trastuzumab
1
Temozolomide
1
Taxes
1
Tamoxifen
1
Quality of Life
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
PF-07284890
1
Nivolumab
1
NEO212
1
Molecular Diagnostic Techniques
1
Midazolam
1
Levofloxacin
1
Lapatinib
1
Ipilimumab
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Drug Therapy
×
Thoracic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled